Alberta Expands Biosimilar Switching With Adalimumab

Canadian Province Adds Humira, Following British Columbia And New Brunswick

 
• By Dave Wallace

Alberta has become the latest Canadian province to expand its biosimilar switching program to cover adalimumab biosimilars to Humira.

Alberta Canada Flags Cracked Wall
Alberta has expanded its biosimilar switching program with Humira • Source: Alamy

More from Biosimilars

More from Products